17601544

Source:http://linkedlifedata.com/resource/pubmed/id/17601544

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0014792, umls-concept:C0018801, umls-concept:C0205314, umls-concept:C0242356, umls-concept:C0487742, umls-concept:C0679622, umls-concept:C1446468, umls-concept:C1511726, umls-concept:C1514475, umls-concept:C1704711, umls-concept:C2728259
pubmed:issue	1
pubmed:dateCreated	2007-7-2
pubmed:abstractText	The goal of this study was to identify potentially novel laboratory markers of risk in chronic heart failure patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/candesartan
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1558-3597
pubmed:author	pubmed-author:AllenLarry ALA, pubmed-author:CHARM Investigators, pubmed-author:FelkerG MichaelGM, pubmed-author:GrangerChristopher BCB, pubmed-author:McMurrayJohn J VJJ, pubmed-author:MichelsonEric LEL, pubmed-author:PfefferMarc AMA, pubmed-author:PocockStuart JSJ, pubmed-author:ShawLinda KLK, pubmed-author:SwedbergKarlK, pubmed-author:WangDuolaoD, pubmed-author:YusufSalimS
pubmed:issnType	Electronic
pubmed:day	3
pubmed:volume	50
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	40-7
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:17601544-Aged, pubmed-meshheading:17601544-Benzimidazoles, pubmed-meshheading:17601544-Biological Markers, pubmed-meshheading:17601544-Cause of Death, pubmed-meshheading:17601544-Cohort Studies, pubmed-meshheading:17601544-Databases as Topic, pubmed-meshheading:17601544-Disease Progression, pubmed-meshheading:17601544-Erythrocytes, pubmed-meshheading:17601544-Female, pubmed-meshheading:17601544-Heart Failure, pubmed-meshheading:17601544-Humans, pubmed-meshheading:17601544-Male, pubmed-meshheading:17601544-Middle Aged, pubmed-meshheading:17601544-Multivariate Analysis, pubmed-meshheading:17601544-Probability, pubmed-meshheading:17601544-Prognosis, pubmed-meshheading:17601544-Proportional Hazards Models, pubmed-meshheading:17601544-Randomized Controlled Trials as Topic, pubmed-meshheading:17601544-Risk Assessment, pubmed-meshheading:17601544-Sensitivity and Specificity, pubmed-meshheading:17601544-Severity of Illness Index, pubmed-meshheading:17601544-Survival Analysis, pubmed-meshheading:17601544-Tetrazoles
pubmed:year	2007
pubmed:articleTitle	Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.
pubmed:affiliation	Duke Clinical Research Institute, Durham, North Carolina, USA. michael.felker@duke.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't